PPARG and Alzheimer disease: Growing evidence revealed that PPARγ agonists (rosiglitazone) could rescue memory impairment of AD model mice (Toledo and Inestrosa, 2010; Escribano et al., 2010; O’Reilly and Lynch, 2012).